3rd week on semaglutide results are in! ๐๐ผ๐ Our beautiful patient just completed 3 months of our medically supervised weight loss program. Over the last 90 days she has continued to exercise and eat a Maintenance for 3 months now.
Description
Limitations and Clinical Implications Despite its robust efficacy, semaglutide also presents several limitations that warrant consideration
It has not undergone full safety and efficacy testing required for approval
This will support blood sugar levels and reduce the risk of cardiovascular diseases
Compared to baseline, BMI (kg/m 2 ) for the semaglutide users decreased by 1.69 units by the third treatment month
Greg Poland says the CDC should not disregard tinnitus as a possible side effect
Three companies Wave Life Sciences, Structure Therapeutics, and Ascletis Pharma Inc
